OTCMKTS:ADOCY Adocia (ADOCY) Stock Price, News & Analysis $11.80 0.00 (0.00%) As of 10/16/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Adocia Stock (OTCMKTS:ADOCY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Adocia alerts:Sign Up Key Stats Today's Range$11.80▼$11.8050-Day Range$11.80▼$11.8052-Week Range$9.80▼$11.80VolumeN/AAverage VolumeN/AMarket Capitalization$238.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Adocia is a France-based clinical-stage biopharmaceutical company focused on developing innovative treatments for diabetes and other metabolic diseases. The company uses its proprietary BioChaperone technology to improve the formulation, stability, absorption and delivery of therapeutic proteins and peptides. Adocia’s development programs have included ultra-rapid insulin products, such as BioChaperone Lispro, as well as combinations of insulin and other metabolic therapies. Its platform is designed to support faster-acting or more convenient treatments than conventional formulations, with the goal of improving blood-glucose management and patient outcomes. Founded in 2005 and headquartered in Lyon, France, Adocia has advanced its programs through internal research and collaborations with pharmaceutical companies. The company has previously entered into development and licensing arrangements with partners including Sanofi and Tonghua Dongbao. Adocia is led by co-founder and Chief Executive Officer Gérard Soula.AI Generated. May Contain Errors. Read More Receive ADOCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adocia and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADOCY Stock News HeadlinesAdocia Reports Share Capital and Voting Rights as of September 30, 2026October 9, 2026 | tipranks.comAdocia Extends Cash Runway as It Pushes China Insulin Filing and Peptide PlatformSeptember 24, 2026 | tipranks.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 18 at 1:00 AM | Weiss Ratings (Ad)Adocia to Showcase AdoShell and Phase 3 BioChaperone Lispro Data at Key Diabetes MeetingsSeptember 17, 2026 | tipranks.comAdocia Reports Updated Share Capital and Voting Rights for August 2026September 10, 2026 | tipranks.comAdocia reshapes board to bolster strategy in diabetes and obesitySeptember 1, 2026 | tipranks.comAdocia Updates Share Capital and Voting Rights After New Share IssuanceAugust 24, 2026 | tipranks.comAdocia Extends Cash Runway as BioChaperone and AdoXLong Platforms Advance in Diabetes and ObesityJuly 23, 2026 | tipranks.comSee More Headlines ADOCY Stock Analysis - Frequently Asked Questions How have ADOCY shares performed this year? Adocia's stock was trading at $11.80 on January 1st, 2026. Since then, ADOCY shares have increased by 0.0% and is now trading at $11.80. How do I buy shares of Adocia? Shares of ADOCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/18/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:ADOCY CIKN/A Webwww.adocia.com Phone33-04-72-61-06-10Fax33-04-72-36-39-67Employees78Year Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.35 million Price / Sales54.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.09 per share Price / Book131.11Miscellaneous Outstanding Shares20,250,000Free FloatN/AMarket Cap$238.95 million OptionableNot Optionable BetaN/A Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:ADOCY) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | SponsoredThis link won't stay freeThe 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightfo...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adocia Please log in to your account or sign up in order to add this asset to your watchlist. Share Adocia With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
